Autoliv (ALV) Investors: BMO Capital Reiterates Buy Rating, Sees $121.0/Share; Juno Therapeutics (JUNO) Shorts Down By 6.42%
Juno Therapeutics Incorporated (NASDAQ:JUNO) had a diminishing of 6.42% in short intrigue. JUNO's SI was 14.72 million offers in Septem...Read More
